Company intelligence / Profile preview

Principal Technologies

Vancouver, British Columbia, Canada

Ownership: Private
Development stage: Other

Overview

Principal Technologies is not a drug-development company; it is a public healthcare technology investment/holding company building a portfolio of med‑tech and healthcare technology assets, with initial activities including project management of international clinical studies for medical devices and a pending acquisition of med‑tech company Vivostat A/S.[1][3][4]

Industry: Investors

Partnerships

Planned fundamental acquisition of Vivostat A/S, a Denmark-based company with an on-site autologous concentrated fibrin and platelet-rich fibrin system[4]

Beyond the preview

Go deeper on Principal Technologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Principal Technologies.

Explore the full profile